Drug intelligence / Profile preview

9Z,11E-conjugated linoleic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**9Z,11E-conjugated linoleic acid** (c9,t11-CLA) is a specific isomer of conjugated linoleic acid (CLA), a naturally occurring fatty acid primarily found in meat and dairy from ruminant animals[2][3][4][5]. CLA consists of different isomers, but the 9Z,11E/cis-9, trans-11 isomer is the most abundant and biologically active form in food sources. 9Z,11E-CLA has potential mechanisms of action that include modulation of lipid metabolism, reduction of body fat, anti-inflammatory and immunomodulatory effects, anti-cancer properties, and cardiovascular benefits[2][4][5]. Its biological effects are thought to be mediated by interactions with nuclear receptors such as peroxisome proliferator-activated receptor gamma (PPARγ), modulating gene expression involved in fat metabolism, inflammation, cell proliferation, and apoptosis[4]. Some studies suggest this isomer can increase adiponectin and endothelial nitric oxide synthase activity, inhibit matrix metalloproteinases involved in tumor invasion, and exert neuroprotective effects[4]. 9Z,11E-CLA is marketed as a dietary supplement for weight loss, metabolic health, and cancer prevention, but human evidence is inconclusive and safety concerns exist regarding insulin resistance and lipid profiles[1][3][5]. There are no pharmaceutical formulations of pure 9Z,11E-CLA; it is typically present as part of multi-isomer CLA dietary supplements.

Brand names
ClarinolPamolyn 300Pamolyn300Pamolyn-300
Other names
cis-9, trans-11 conjugated linoleic acidc9,t11-CLAconjugated linoleic acid
02

Targets

NOS3 (eNOS)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on 9Z,11E-conjugated linoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 9Z,11E-conjugated linoleic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call